Role of Rebound Therapy in the Rehabilitation of Children With Spastic Cerebral Palsy

Cerebral Palsy Clinical Trial

Official title:

Role of Rebound Therapy in the Rehabilitation of Children With Spastic Cerebral Palsy

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04712708
• Other study ID #: P.T. REC/012/002421
• Status: Recruiting
• Phase: N/A
• Start date: November 1, 2020
• Est. completion date: July 30, 2021

Study information

• Verified date: December 2020
• Source: Cairo University
• Contact: Faten Abdelaziem, PhD
• Phone: +20 100 855 4818
• Email: faten.hassan[@]pt.cu.edu.eg
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Cerebral palsy (CP) is a group of disorders of movement and posture, causing several body impairments. CP is caused by non-progressive disturbance that occurred in the fetal or immature brain. CP symptoms include several motor disorders such as disturbances in sensation, coordination, cognition, communication and behavior in addition to disturbances in postural stability, balance and coordination. Balance is the ability to maintain the center of body mass over the base of support. CP causes balance impairment which results in decrease in the child's mobility functions and causing activity limitation and participations restrictions. Motor coordination is the registration of two or more things such as body movements , timing or sensory feedback into a harmonious relationship. CP causes disturbances in motor coordination such as difficulties in the routine gross movements as running and jumping, and disturbances in common fine movements like buttoning, clothing or brushing hair Rebound therapy is an exercise therapy which uses mini trampolines, rebounders , Springfree Trampoline and Swiss balls, to provide opportunity to perform recreational movements for individuals with different body structural and functional impairments.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 32
• Est. completion date: July 30, 2021
• Est. primary completion date: July 30, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 5 Years to 11 Years

Eligibility

Inclusion Criteria:

• Spastic cerebral palsy was determined according to the sample size calculation, was selected from the outpatient's clinic of the faculty of Physical Therapy Cairo University.
• Level I according to the Gross Motor Function Classification System (GMFCS). Chronological age ranged from 5 to 11 years.
• Height was above 1 meter.
• Understand verbal command.
• The degree of spasticity ranged from 1 to 1+ according to Modified Ashworth' Scale. Rebound therapy using trampoline was used as the method of management in the study group in addition to the selected physical therapy program that was used in both groups, and the treatment sessions was provided in the out-patient clinic of the faculty of Physical Therapy Cairo University.

Exclusion Criteria:

• Vertigo or dizziness.
• Epilepsy.
• Osteoporosis.

Related Conditions & MeSH terms

• Cerebral Palsy

Intervention

Device:
• Rebound Therapy
Rebound therapy is the therapeutic use of full sized trampoline or mini sized trampoline. It provides opportunities for exercise recreation and therapy; and it is distinct from gymnastic trampolining. It is used for facilitating movements, improving balance, enhancing coordination and promoting motor performances in children with different disorders includes learning disabilities, communication disorders and motor dysfunction (Rebound Therapy South Africa, 2020; The Chartered society of Physiotherapists, 2016).

Other:
• Physical Therapy Program
The Mat Exercises: Stretching exercises to all spastic muscle groups (Kalkman et al., 2018). Gentle exercises was applied for 40-60 seconds and repeated from 3-5 times/ movement as supported by (Fragala et al., 2003). Strengthening Exercises: Dynamic Rising Positioning The Gym Exercises:

Locations

Country	Name	City	State
Egypt	Faculty of Physical Therapy Cairo University	Giza

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Balance	Stationary Balance Using Biodex Balance System	12 Weeks
Primary	Gross Motor Function	Gross Motor Function using Gross Motor Function Measure (GMFM)	12 Weeks
Primary	Gross Motor Coordination	Gross Motor Coordination Using Gross Motor Coordination Quotient in BOT-2	12 Weeks